secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0001654954-24-006133
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata Therapeutics to effect 1:15 reverse stock split on May 16, 2024
-----------------------------------------------------------------------

- Shareholders authorized reverse split ratio between 1:5 and 1:30; Board selected 1:15 on May 8.
- Every 15 existing shares convert to 1 share; no fractional shares, cash paid in lieu.
- CUSIP changes to 249845405; trading on Nasdaq on split-adjusted basis expected May 16.
- Outstanding options and warrants adjusted proportionally; par value and authorized shares unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424006133/0001654954-24-006133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424006133/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-006133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer